Conversely, BRCA1 carriers have more than 3.3-fold increased probability of having ER-negative disease compared with the general BC population, which suggests that loss of BRCA1 function may be a contributing factor to the development of ER-negative BC. Here, BRCA1 is linked to breast cancer.